Alzheimer’s Research UK announces ‘cannabis-based’ Sativex trial for dementia

The UK’s leading dementia research charity Alzheimer’s Research UK has announced it will fund a “pioneering” clinical trial at King’s College London using the “cannabis-based” treatment Sativex for people living with dementia. Sativex is a peppermint-flavoured mouth spray that contains a 1:1 ratio of two key cannabinoids found in the cannabis plant – delta-9-tetrahydrocannabinol (THC) […]

Continue Reading

WHO recommends rescheduling cannabis and descheduling pure CBD – reaction

The World Health Organization’s Expert Committee on Drug Dependence (ECDD) has told the United Nations Commission on Narcotic Drugs (CND) that cannabis and cannabis resin should be removed from Schedule IV of the 1961 Convention, the category reserved for the most dangerous substances.  In 1954 the WHO started an initiative to eradicate cannabis from the […]

Continue Reading

Raphael Mechoulam joins GW Pharma hoping for a “fruitful collaboration”

The “godfather” of cannabis science is teaming up with the UK cannabis giant GW Pharmaceuticals, the world’s largest exporter of medicinal cannabis. In amongst the mass of news pouring out from North America as they steam ahead with recreational legalistion, the pharmaceutical powerhouse GW Pharmaceuticals has largely been left unchallenged in the UK despite rumours […]

Continue Reading

Parents of 35 UK epileptic children demand THC cannabis oil

Parents of Hope are mothers and fathers still living in fear for their children who are having access to legal medical cannabis products blocked through Britain’s culture of fear around THC. There are currently 35 Children in the UK that are in urgent need of whole plant medicinal cannabis, including THC. Today the parents have […]

Continue Reading